Global Investigational New Drug CDMO Market Size study, by Product (Small Molecule, Large Molecule), by Service (Contract Development, Contract Manufacturing), by End-User (Pharmaceutical Companies, Biotech Companies, Others), and Regional Forecasts 2021-2027
Global investigational new drug CDMO market is valued approximately at USD 4.2 billion in 2020 and is anticipated to grow with a healthy growth rate of about 6.9% over the forecast period 2021-2027. A CDMO (contract development and manufacturing company) refers to a company within the pharmaceutical industry which offers drug manufacturing and development services. Companies active in the pharmaceutical sector partner with contract development and manufacturing company in order to outsource drug manufacturing and drug development. The global investigational new drug CDMO market is being driven by increasing outsourcing services by pharmaceutical companies and growing pharmaceutical industry across the globe. Furthermore, rising investment in research and development will provide new opportunities for the global investigational new drug CDMO industry. According to Statista, the total spending on pharmaceutical research and development across the globe is expected to increase from USD 137 billion in 2012 to approximately USD 254 billion by 2026. Such growth in the spending on pharmaceutical research and development across the globe is expected to increase the adoption of contract development and manufacturing for drug development and hence this is expected to boost the market growth. However, compliance issues while outsourcing may impede market growth over the forecast period of 2021-2027.
The regional analysis of the global investigational new drug CDMO market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America accounts for the largest share in terms of market revenue in the global investigational new drug CDMO market over the forecast period 2021-2027. Factors such as increased research and development investments by pharmaceutical and life sciences companies, increase in the prevalence of a range of diseases and disorders, initiatives for drug development and manufacturing across countries such as the United States and Canada, etc. contribute towards the largest market share of the region in the forecast years.
Major market player included in this report are:
Covance Inc.
Charles River Laboratories Inc.
Cambrex Corporation
IQVIA Holdings Inc.
Syneos Health
Lonza
Catalent
Recipharm AB
Siegfried Holding AG
Thermo Fisher Scientific Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Small Molecule
Large Molecule
By Service:
Contract Development
Contract Manufacturing
By End-User:
Pharmaceutical Companies
Biotech Companies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Investigational New Drug CDMO Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of the global investigational new drug CDMO market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America accounts for the largest share in terms of market revenue in the global investigational new drug CDMO market over the forecast period 2021-2027. Factors such as increased research and development investments by pharmaceutical and life sciences companies, increase in the prevalence of a range of diseases and disorders, initiatives for drug development and manufacturing across countries such as the United States and Canada, etc. contribute towards the largest market share of the region in the forecast years.
Major market player included in this report are:
Covance Inc.
Charles River Laboratories Inc.
Cambrex Corporation
IQVIA Holdings Inc.
Syneos Health
Lonza
Catalent
Recipharm AB
Siegfried Holding AG
Thermo Fisher Scientific Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Small Molecule
Large Molecule
By Service:
Contract Development
Contract Manufacturing
By End-User:
Pharmaceutical Companies
Biotech Companies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Investigational New Drug CDMO Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Investigational New Drug CDMO Market, by Region, 2019-2027 (USD Billion)
1.2.2. Investigational New Drug CDMO Market, by Product, 2019-2027 (USD Billion)
1.2.3. Investigational New Drug CDMO Market, by Service, 2019-2027 (USD Billion)
1.2.4. Investigational New Drug CDMO Market, by End-User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET DYNAMICS
3.1. Investigational New Drug CDMO Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing pharmaceutical industry
3.1.1.2. Increasing outsourcing services by pharmaceutical companies
3.1.2. Market Restraint
3.1.2.1. Compliance issues while outsourcing
3.1.3. Market Opportunities
3.1.3.1. Rising investment in R&D
CHAPTER 4. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET, BY PRODUCT
a. Market Snapshot
5.1. Global Investigational New Drug CDMO Market by Product, Performance - Potential Analysis
5.2. Global Investigational New Drug CDMO Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.3. Investigational New Drug CDMO Market, Sub Segment Analysis
5.3.1. Small Molecule
5.3.2. Large Molecule
CHAPTER 6. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET, BY SERVICE
b. Market Snapshot
6.1. Global Investigational New Drug CDMO Market by Service, Performance - Potential Analysis
6.2. Global Investigational New Drug CDMO Market Estimates & Forecasts by Service 2018-2027 (USD Billion)
6.3. Investigational New Drug CDMO Market, Sub Segment Analysis
6.3.1. Contract Development
6.3.2. Contract Manufacturing
CHAPTER 7. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET, BY END-USER
c. Market Snapshot
7.1. Global Investigational New Drug CDMO Market by End-User, Performance - Potential Analysis
7.2. Global Investigational New Drug CDMO Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)
7.3. Investigational New Drug CDMO Market, Sub Segment Analysis
7.3.1. Pharmaceutical Companies
7.3.2. Biotech Companies
7.3.3. Others
CHAPTER 8. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET, REGIONAL ANALYSIS
8.1. Investigational New Drug CDMO Market, Regional Market Snapshot
8.2. North America Investigational New Drug CDMO Market
8.2.1. U.S. Investigational New Drug CDMO Market
8.2.1.1. Product breakdown estimates & forecasts, 2018-2027
8.2.1.2. Service breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-User breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Investigational New Drug CDMO Market
8.3. Europe Investigational New Drug CDMO Market Snapshot
8.3.1. U.K. Investigational New Drug CDMO Market
8.3.2. Germany Investigational New Drug CDMO Market
8.3.3. France Investigational New Drug CDMO Market
8.3.4. Spain Investigational New Drug CDMO Market
8.3.5. Italy Investigational New Drug CDMO Market
8.3.6. Rest of Europe Investigational New Drug CDMO Market
8.4. Asia-Pacific Investigational New Drug CDMO Market Snapshot
8.4.1. China Investigational New Drug CDMO Market
8.4.2. India Investigational New Drug CDMO Market
8.4.3. Japan Investigational New Drug CDMO Market
8.4.4. Australia Investigational New Drug CDMO Market
8.4.5. South Korea Investigational New Drug CDMO Market
8.4.6. Rest of Asia Pacific Investigational New Drug CDMO Market
8.5. Latin America Investigational New Drug CDMO Market Snapshot
8.5.1. Brazil Investigational New Drug CDMO Market
8.5.2. Mexico Investigational New Drug CDMO Market
8.6. Rest of The World Investigational New Drug CDMO Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Covance Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Charles River Laboratories Inc.
9.2.3. Cambrex Corporation
9.2.4. IQVIA Holdings Inc.
9.2.5. Syneos Health
9.2.6. Lonza
9.2.7. Catalent
9.2.8. Recipharm AB
9.2.9. Siegfried Holding AG
9.2.10. Thermo Fisher Scientific Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Investigational New Drug CDMO Market, by Region, 2019-2027 (USD Billion)
1.2.2. Investigational New Drug CDMO Market, by Product, 2019-2027 (USD Billion)
1.2.3. Investigational New Drug CDMO Market, by Service, 2019-2027 (USD Billion)
1.2.4. Investigational New Drug CDMO Market, by End-User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET DYNAMICS
3.1. Investigational New Drug CDMO Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing pharmaceutical industry
3.1.1.2. Increasing outsourcing services by pharmaceutical companies
3.1.2. Market Restraint
3.1.2.1. Compliance issues while outsourcing
3.1.3. Market Opportunities
3.1.3.1. Rising investment in R&D
CHAPTER 4. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET, BY PRODUCT
a. Market Snapshot
5.1. Global Investigational New Drug CDMO Market by Product, Performance - Potential Analysis
5.2. Global Investigational New Drug CDMO Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.3. Investigational New Drug CDMO Market, Sub Segment Analysis
5.3.1. Small Molecule
5.3.2. Large Molecule
CHAPTER 6. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET, BY SERVICE
b. Market Snapshot
6.1. Global Investigational New Drug CDMO Market by Service, Performance - Potential Analysis
6.2. Global Investigational New Drug CDMO Market Estimates & Forecasts by Service 2018-2027 (USD Billion)
6.3. Investigational New Drug CDMO Market, Sub Segment Analysis
6.3.1. Contract Development
6.3.2. Contract Manufacturing
CHAPTER 7. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET, BY END-USER
c. Market Snapshot
7.1. Global Investigational New Drug CDMO Market by End-User, Performance - Potential Analysis
7.2. Global Investigational New Drug CDMO Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)
7.3. Investigational New Drug CDMO Market, Sub Segment Analysis
7.3.1. Pharmaceutical Companies
7.3.2. Biotech Companies
7.3.3. Others
CHAPTER 8. GLOBAL INVESTIGATIONAL NEW DRUG CDMO MARKET, REGIONAL ANALYSIS
8.1. Investigational New Drug CDMO Market, Regional Market Snapshot
8.2. North America Investigational New Drug CDMO Market
8.2.1. U.S. Investigational New Drug CDMO Market
8.2.1.1. Product breakdown estimates & forecasts, 2018-2027
8.2.1.2. Service breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-User breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Investigational New Drug CDMO Market
8.3. Europe Investigational New Drug CDMO Market Snapshot
8.3.1. U.K. Investigational New Drug CDMO Market
8.3.2. Germany Investigational New Drug CDMO Market
8.3.3. France Investigational New Drug CDMO Market
8.3.4. Spain Investigational New Drug CDMO Market
8.3.5. Italy Investigational New Drug CDMO Market
8.3.6. Rest of Europe Investigational New Drug CDMO Market
8.4. Asia-Pacific Investigational New Drug CDMO Market Snapshot
8.4.1. China Investigational New Drug CDMO Market
8.4.2. India Investigational New Drug CDMO Market
8.4.3. Japan Investigational New Drug CDMO Market
8.4.4. Australia Investigational New Drug CDMO Market
8.4.5. South Korea Investigational New Drug CDMO Market
8.4.6. Rest of Asia Pacific Investigational New Drug CDMO Market
8.5. Latin America Investigational New Drug CDMO Market Snapshot
8.5.1. Brazil Investigational New Drug CDMO Market
8.5.2. Mexico Investigational New Drug CDMO Market
8.6. Rest of The World Investigational New Drug CDMO Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Covance Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Charles River Laboratories Inc.
9.2.3. Cambrex Corporation
9.2.4. IQVIA Holdings Inc.
9.2.5. Syneos Health
9.2.6. Lonza
9.2.7. Catalent
9.2.8. Recipharm AB
9.2.9. Siegfried Holding AG
9.2.10. Thermo Fisher Scientific Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 2. Global Investigational New Drug CDMO Market, report scope
TABLE 3. Global Investigational New Drug CDMO Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 4. Global Investigational New Drug CDMO Market estimates & forecasts by Product 2018-2027 (USD Billion)
TABLE 5. Global Investigational New Drug CDMO Market estimates & forecasts by Service 2018-2027 (USD Billion)
TABLE 6. Global Investigational New Drug CDMO Market estimates & forecasts by End-User 2018-2027 (USD Billion)
TABLE 7. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. U.S. Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. U.S. Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. Canada Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. Canada Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. UK Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. UK Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. Germany Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. Germany Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. France Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. France Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. Spain Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Spain Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. Italy Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Italy Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. ROE Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. ROE Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. China Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. China Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. India Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. India Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. Japan Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Japan Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 57. Australia Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. Australia Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 60. South Korea Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. South Korea Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 63. ROPAC Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. ROPAC Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 66. Brazil Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Brazil Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 69. Mexico Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. Mexico Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 72. ROLA Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROLA Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 75. ROW Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. ROW Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 77. List of secondary sources used in the study of global Investigational New Drug CDMO Market.
TABLE 78. List of primary sources used in the study of global Investigational New Drug CDMO Market.
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered.
TABLE 2. Global Investigational New Drug CDMO Market, report scope
TABLE 3. Global Investigational New Drug CDMO Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 4. Global Investigational New Drug CDMO Market estimates & forecasts by Product 2018-2027 (USD Billion)
TABLE 5. Global Investigational New Drug CDMO Market estimates & forecasts by Service 2018-2027 (USD Billion)
TABLE 6. Global Investigational New Drug CDMO Market estimates & forecasts by End-User 2018-2027 (USD Billion)
TABLE 7. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Investigational New Drug CDMO Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. Global Investigational New Drug CDMO Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. U.S. Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. U.S. Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. Canada Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. Canada Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. UK Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. UK Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. Germany Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. Germany Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. France Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. France Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. Spain Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Spain Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. Italy Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Italy Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. ROE Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. ROE Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. China Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. China Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. India Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. India Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. Japan Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Japan Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 57. Australia Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. Australia Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 60. South Korea Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. South Korea Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 63. ROPAC Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. ROPAC Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 66. Brazil Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Brazil Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 69. Mexico Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. Mexico Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 72. ROLA Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROLA Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Investigational New Drug CDMO Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 75. ROW Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. ROW Investigational New Drug CDMO Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 77. List of secondary sources used in the study of global Investigational New Drug CDMO Market.
TABLE 78. List of primary sources used in the study of global Investigational New Drug CDMO Market.
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered.
LIST OF FIGURES
FIG 1. Global Investigational New Drug CDMO Market, research methodology
FIG 2. Global Investigational New Drug CDMO Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Investigational New Drug CDMO Market, key trends 2020
FIG 5. Global Investigational New Drug CDMO Market, growth prospects 2021-2027
FIG 6. Global Investigational New Drug CDMO Market, porters 5 force model
FIG 7. Global Investigational New Drug CDMO Market, pest analysis
FIG 8. Global Investigational New Drug CDMO Market, value chain analysis
FIG 9. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Investigational New Drug CDMO Market, regional snapshot 2018 & 2027
FIG 18. North America Investigational New Drug CDMO Market2018 & 2027 (USD Billion)
FIG 19. Europe Investigational New Drug CDMO Market2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Investigational New Drug CDMO Market2018 & 2027 (USD Billion)
FIG 21. Latin America Investigational New Drug CDMO Market2018 & 2027 (USD Billion)
FIG 22. Global Investigational New Drug CDMO Market, company market share analysis (2020)
FIG 1. Global Investigational New Drug CDMO Market, research methodology
FIG 2. Global Investigational New Drug CDMO Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Investigational New Drug CDMO Market, key trends 2020
FIG 5. Global Investigational New Drug CDMO Market, growth prospects 2021-2027
FIG 6. Global Investigational New Drug CDMO Market, porters 5 force model
FIG 7. Global Investigational New Drug CDMO Market, pest analysis
FIG 8. Global Investigational New Drug CDMO Market, value chain analysis
FIG 9. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Investigational New Drug CDMO Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Investigational New Drug CDMO Market, regional snapshot 2018 & 2027
FIG 18. North America Investigational New Drug CDMO Market2018 & 2027 (USD Billion)
FIG 19. Europe Investigational New Drug CDMO Market2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Investigational New Drug CDMO Market2018 & 2027 (USD Billion)
FIG 21. Latin America Investigational New Drug CDMO Market2018 & 2027 (USD Billion)
FIG 22. Global Investigational New Drug CDMO Market, company market share analysis (2020)
